Overview
Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Intercostal Nerve Block for Chronic Post-thoracotomy Pain
Status:
Recruiting
Recruiting
Trial end date:
2022-12-30
2022-12-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
The patients were divided into two groups by random number method: GroupRD1 group and GroupRD2 group were given general anesthesia and intercostal nerve block.The drug for intercostal nerve block was 0.33% ropivacaine +2.333mg compound betamethasone (1.667mg betamethasone dipropionate + 0.667mg betamethasone sodium phosphate) to 15ml.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Affiliated Hospital of Nantong UniversityTreatments:
Betamethasone
Ropivacaine
Criteria
Inclusion Criteria:1. 18-70 years old
2. ASA grade I-III
3. BMI: 18.5-28kg/m2
4. Type of surgery: elective thoracoscopic lung mass resection
5. Informed consent has been signed by the patient and/or family members
Exclusion Criteria:
1. game anesthesia or sugar cortical hormone drugs allergic
2. preoperative use of opioid medicines
3. serious blood coagulation dysfunction
4. serious heart, lung, liver and renal insufficiency
5. put, chemotherapy, and glucocorticoid immunosuppressive therapy history or diseases of
the immune system
6. peptic ulcer
7. newly gastrointestinal surgery
8. has a history of thoracic surgery
9. is the central nervous system disease
10. Other glucocorticoids should be used with caution in patients such as fractures, wound
repair, corneal ulcers, hyperadrenocortical disease, diabetes mellitus, pregnant
women, etc.